These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28829407)

  • 1. In Quest for Improved Drugs against Diabetes: The Added Value of X-ray Powder Diffraction Methods.
    Karavassili F; Valmas A; Fili S; Georgiou CD; Margiolaki I
    Biomolecules; 2017 Aug; 7(3):. PubMed ID: 28829407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macromolecular Powder Diffraction: Ready for genuine biological problems.
    Karavassili F; Margiolaki I
    Protein Pept Lett; 2016; 23(3):232-41. PubMed ID: 26786768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin polymorphism induced by two polyphenols: new crystal forms and advances in macromolecular powder diffraction.
    Triandafillidis DP; Parthenios N; Spiliopoulou M; Valmas A; Kosinas C; Gozzo F; Reinle-Schmitt M; Beckers D; Degen T; Pop M; Fitch AN; Wollenhaupt J; Weiss MS; Karavassili F; Margiolaki I
    Acta Crystallogr D Struct Biol; 2020 Nov; 76(Pt 11):1065-1079. PubMed ID: 33135678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel crystalline phase and first-order phase transitions of human insulin complexed with two distinct phenol derivatives.
    Valmas A; Magiouf K; Fili S; Norrman M; Schluckebier G; Beckers D; Degen T; Wright J; Fitch A; Gozzo F; Giannopoulou AE; Karavassili F; Margiolaki I
    Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):819-28. PubMed ID: 25849393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T
    Triandafillidis DP; Karavassili F; Spiliopoulou M; Valmas A; Athanasiadou M; Nikolaras G; Fili S; Kontou P; Bowler MW; Chasapis CT; Von Dreele RB; Fitch AN; Margiolaki I
    Acta Crystallogr D Struct Biol; 2023 May; 79(Pt 5):374-386. PubMed ID: 37039669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first protein crystal structure determined from high-resolution X-ray powder diffraction data: a variant of T3R3 human insulin-zinc complex produced by grinding.
    Von Dreele RB; Stephens PW; Smith GD; Blessing RH
    Acta Crystallogr D Biol Crystallogr; 2000 Dec; 56(Pt 12):1549-53. PubMed ID: 11092920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising Potential of Dietary (Poly)Phenolic Compounds in the Prevention and Treatment of Diabetes Mellitus.
    Dias TR; Alves MG; Casal S; Oliveira PF; Silva BM
    Curr Med Chem; 2017; 24(4):334-354. PubMed ID: 27593957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD).
    Fütterer S; Andrusenko I; Kolb U; Hofmeister W; Langguth P
    J Pharm Biomed Anal; 2013 Dec; 86():151-60. PubMed ID: 23998966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Polymorphic Forms of Active Pharmaceutical Ingredient in Low-Concentration Dry Powder Formulations by Synchrotron X-Ray Powder Diffraction.
    Egusa K; Okazaki F; Schiewe J; Werthmann U; Wolkenhauer M
    Drugs R D; 2017 Sep; 17(3):413-418. PubMed ID: 28905245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the complex map of insulin polymorphism: a novel crystalline form in the presence of m-cresol.
    Karavassili F; Valmas A; Dimarogona M; Giannopoulou AE; Fili S; Norrman M; Schluckebier G; Beckers D; Fitch AN; Margiolaki I
    Acta Crystallogr D Struct Biol; 2020 Apr; 76(Pt 4):366-374. PubMed ID: 32254061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New perspectives in macromolecular powder diffraction using single-photon-counting strip detectors: high-resolution structure of the pharmaceutical peptide octreotide.
    Spiliopoulou M; Karavassili F; Triandafillidis DP; Valmas A; Fili S; Kosinas C; Barlos K; Barlos KK; Morin M; Reinle-Schmitt ML; Gozzo F; Margiolaki I
    Acta Crystallogr A Found Adv; 2021 May; 77(Pt 3):186-195. PubMed ID: 33944797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal morphologies and polymorphs in tolbutamide microcrystalline powder.
    Li Destri G; Marrazzo A; Rescifina A; Punzo F
    J Pharm Sci; 2013 Jan; 102(1):73-83. PubMed ID: 23042550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human insulin polymorphism upon ligand binding and pH variation: the case of 4-ethylresorcinol.
    Fili S; Valmas A; Norrman M; Schluckebier G; Beckers D; Degen T; Wright J; Fitch A; Gozzo F; Giannopoulou AE; Karavassili F; Margiolaki I
    IUCrJ; 2015 Sep; 2(Pt 5):534-44. PubMed ID: 26306195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution powder X-ray data reveal the T(6) hexameric form of bovine insulin.
    Margiolaki I; Giannopoulou AE; Wright JP; Knight L; Norrman M; Schluckebier G; Fitch AN; Von Dreele RB
    Acta Crystallogr D Biol Crystallogr; 2013 Jun; 69(Pt 6):978-90. PubMed ID: 23695242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein crystal structure analysis from high-resolution X-ray powder-diffraction data.
    Von Dreele RB
    Methods Enzymol; 2003; 368():254-67. PubMed ID: 14674278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Powder crystallography on macromolecules.
    Margiolaki I; Wright JP
    Acta Crystallogr A; 2008 Jan; 64(Pt 1):169-80. PubMed ID: 18156682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-Ray powder diffraction - A non-destructive and versatile approach for the identification of new psychoactive substances.
    Jurásek B; Bartůněk V; Huber Š; Kuchař M
    Talanta; 2019 Apr; 195():414-418. PubMed ID: 30625563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of Powder X-Ray Diffraction in Small Molecule Pharmaceuticals: Achievements and Aspirations.
    Thakral NK; Zanon RL; Kelly RC; Thakral S
    J Pharm Sci; 2018 Dec; 107(12):2969-2982. PubMed ID: 30145209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring high-throughput synchrotron X-Ray powder diffraction for the structural analysis of pharmaceuticals.
    Reinle-Schmitt M; Šišak Jung D; Morin M; Costa FN; Casati N; Gozzo F
    Int J Pharm X; 2023 Dec; 6():100221. PubMed ID: 38146324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic products in coordination networks: ab initio X-ray powder diffraction analysis.
    Martí-Rujas J; Kawano M
    Acc Chem Res; 2013 Feb; 46(2):493-505. PubMed ID: 23252592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.